Publications
Learn more about our published research and the science behind the PromarkerEso test
Latest publications
World first blood test for esophageal cancer shows 94% accuracy in clinical validation study
Latest results validate biomarkers for PromarkerEso blood test for oesophageal adenocarcinoma
A novel serum glycoprotein biomarker panel
for screening of esophageal adenocarcinoma
and surveillance of Barrett’s esophagus
A novel serum glycoprotein biomarker panel for screening of esophageal adenocarcinoma and surveillance of Barrett’s esophagus
Oral Presented by R. Lipscombe. R. Lipscombe M.N. Duong, R. Casey, G. Fernadez, S. Bringans, K. Peters, M.M. Hill, P. Tan, L. Chen.19th ISDE World Congress for Esophageal Diseases in Toronto, September 2023.
Evaluation of Serum Glycoprotein Biomarker Candidates for Detection of Esophageal Adenocarcinoma and Surveillance of Barrett’s Esophagus
A.K Shah, G. Hartel, I. Brown, C. Winterford, R. Na, K. Le Cao, B.A. Spicer, M.A. Dunstone, W.A. Phillips, R.V. Lord, A.P. Barbour, D.I. Watson, V. Joshi, D.C. Whiteman, M.M. Hill; Mol Cell Proteomics 2018; 17(12): 2324–2334.